483
Lilly del Caribe, IncLilly del Caribe, Inc – FDA 483, Jan 30, 2026
Record Details
An FDA inspection of Lilly del Caribe, Inc. in Carolina, PR, a drug product manufacturer, revealed two significant observations. The firm's quality control unit failed to maintain adequate controls over non-batch controlled forms, resulting in numerous missing documents. Additionally, the facility's buildings used for manufacturing and warehousing were found to be infested with various pests, indicating a lack of proper pest control.
View Company Profile
ID · ec06632e-9749-4768-ba9f-878d601b6ada
Other documents for Lilly del Caribe, Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.